drugset / Trial / NCT03302039

Three Protocols for Phenylephrine Administration in Cesarean Delivery

NCT03302039

Phase 4 Completed 217 enrolled Cairo University
RandomizedParallel-groupTriple-blindPrevention

Summary

The investigators will compare variable infusion of phenylephrine (at a starting rate of 0.75 mcg/Kg/min) with fixed rate (0.75 mcg/Kg/min which will stop of reactive hypertension occurred) and single shot (1.5 mcg/Kg) phenylephrine.

Timeline

Start
2017-10-06
Primary completion
2018-10-01
Completion
2018-10-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Phenylephrine Small molecule 0.75 ug/kg Intravenous
Subject Phenylephrine Small molecule 1.5 ug/kg Intravenous
Background Bupivacaine Other / unclassified Intrathecal

Indications

No indication recorded.